Page last updated: 2024-11-07

carbachol and Leukemia

carbachol has been researched along with Leukemia in 2 studies

Carbachol: A slowly hydrolyzed CHOLINERGIC AGONIST that acts at both MUSCARINIC RECEPTORS and NICOTINIC RECEPTORS.

Leukemia: A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Peracchi, M1
Maiolo, AT1
Lombardi, L1
Catena, FB1
Polli, EE1
Laskowska-Bozek, H1
Bany, U1
Stokarska, G1
Ryzewski, J1

Other Studies

2 other studies available for carbachol and Leukemia

ArticleYear
Patterns of cyclic nucleotides in normal and leukaemic human leucocytes.
    British journal of cancer, 1980, Volume: 41, Issue:3

    Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Adenylyl Cyclases; Carbachol; Cyclic AMP; Cyclic GMP; Guanylate

1980
Accumulation of inositol phosphates in human lymphocytes after cholinergic stimulation.
    Acta biochimica Polonica, 1993, Volume: 40, Issue:1

    Topics: Carbachol; Humans; Inositol Phosphates; Leukemia; Lymphocyte Activation; Lymphocytes; Nicotine; Rece

1993